Manufacturing Chemist
  • Home
  • Categories
    • Ingredients
    • Analysis
    • Manufacturing
    • Finance
    • Company News
    • Regulatory
    • Drug Delivery
    • Research & Development
    • Sustainability
  • Pharma 5.0
  • Events
  • Directory
  • Editorial team
  • Search
    • Close search
  • Subscribe
  • Login
    • Password
      Password
      Forgot password? Close login form
  • Home
  • Company News

Company News

Neurocentrx appoints two industry heavyweights its board Neurocentrx appoints two industry heavyweights its board Neurocentrx appoints two industry heavyweights its board Professor David Clifton joins Drayson Health as Research Director Professor David Clifton joins Drayson Health as Research Director Professor David Clifton joins Drayson Health as Research Director MRC welcomes Professor Fiona Watt MRC welcomes Professor Fiona Watt Vifor Pharma proposes Jacques Theurillat as board member Vifor Pharma proposes Jacques Theurillat as board member Emergex builds its Finance Team with two new recruits Emergex builds its Finance Team with two new recruits Mediclinic CEO succession and changes to the board Mediclinic CEO succession and changes to the board Cerecor appoints Peter Greenleaf CEO Cerecor appoints Peter Greenleaf CEO Clinipace appoints Senior VP of operations Clinipace appoints Senior VP of operations Dimerix appoints Chief Medical Officer Dimerix appoints Chief Medical Officer Langguth America hires Territory Manager Langguth America hires Territory Manager Dani Bach joins Crescendo Biologics Dani Bach joins Crescendo Biologics Dani Bach joins Crescendo Biologics GMP Pharmaceuticals announces General Manager appointment GMP Pharmaceuticals announces General Manager appointment GMP Pharmaceuticals announces General Manager appointment Soren Tulstrup appointed new President and CEO of Hansa Medical Soren Tulstrup appointed new President and CEO of Hansa Medical Soren Tulstrup appointed new President and CEO of Hansa Medical Valbiotis appoints new Director of Development and Medical Affairs Valbiotis appoints new Director of Development and Medical Affairs Owen Mumford appoints Garry Hodges as Group Operations Director  Owen Mumford appoints Garry Hodges as Group Operations Director Owen Mumford appoints Garry Hodges as Group Operations Director Professor Kari Rissanen receives prestigious research award Professor Kari Rissanen receives prestigious research award Professor Kari Rissanen receives prestigious research award
  • Previous
  • 1
  • …
  • 57
  • 58
  • 59
  • 60 (current)
  • 61
  • 62
  • 63
  • …
  • 216
  • Next

Trending Articles

  1. Gerresheimer names new Chairman of the Supervisory Board This year's AGM featured the election of four shareholder representatives to the Supervisory Board, including Sieger as Chairman
  2. Yusen Logistics appoints Gilbert den Bekker as chief commercial officer for Europe Experienced commercial leader joins Yusen Logistics to support sustainable growth and strengthen commercial collaboration across Europe
  3. CordenPharma appoints Dr Jean-Luc Herbeaux as Chief Executive Officer Leadership transition marks the next phase of growth following 12 years of transformation under Dr Michael Quirmbach
  4. Scenic Biotech appoints renowned neurology drug development leader Dr. Judith Walker as Chief Medical Officer Dr. Walker joins to lead Scenic's transition into clinical development and shape its clinical strategy
  5. Hovione appoints Stefan Doboczky as Chief Executive Officer Chairman of the board of directors Stefan Doboczky to take over operational leadership of the family-owned pharmaceutical technology and services group on April 1, 2027

Upcoming event

CPhI Milan

6–8 October 2026 | Exhibition | Fiera Milano, Italy
See all

Become a Subscriber

Subscribe now Already a subscriber? Sign in here. Find out more

Get our newsletter

Follow us

  • LinkedIn
  • About Manufacturing Chemist
  • About HPCi Media
  • Newsletter sign up
  • Contact Us
  • Advertise
© HPCi Media Limited | Registered in England No. 06716035 | VAT GB 939828072 | a Claverley Group company Registered office address:
One Anchorage Avenue,
Shrewsbury Business Park,
Shrewsbury,
SY2 6FG, UK. Terms and Conditions | Privacy